Company intelligence
GondolaBio
Creating new and meaningful medicines for patients with genetic diseases
About GondolaBio
GondolaBio is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients living with genetic diseases. A sister company of BridgeBio Pharma, GondolaBio aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, modalities, and stages ranging from early discovery to clinical development. Its team of experienced drug discoverers, developers and innovators are committed to translating advances in genetic science into medicines that can help patients as quickly as possible.
Verified activity
Signals from GondolaBio
2 published signals
Presence & Recognition
GondolaBio shared Adrienne's story on PKDAwarenessDay to raise awareness of the realities of living with polycystic kidney disease.
Reported by GondolaBio
Presence & Recognition
GondolaBio participated in the CharcotMarieTooth Awareness Month to raise awareness for people and families living with CMT
Reported by GondolaBio